Anti-PD-1 treatment stimulates CD8+ cells to secrete IFN-γ, which supposedly reduces the amount of infiltrating Tregs by inhibiting tumor-induced Treg proliferation and recruitment, without statistical significance [148,174,175,176]. The gene discussed is CD8A; the disease is neoplasm.